Two Sigma Advisers’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-737,900
Closed -$1.62M 347
2025
Q4
$1.62M Buy
737,900
+406,900
+123% +$1.01M ﹤0.01% 1273
2025
Q3
$775K Sell
331,000
-82,600
-20% -$142K ﹤0.01% 1584
2025
Q2
$629K Sell
413,600
-57,900
-12% -$90.3K ﹤0.01% 1649
2025
Q1
$653K Sell
471,500
-360,400
-43% -$768K ﹤0.01% 1668
2024
Q4
$1.89M Buy
831,900
+550,700
+196% +$1.93M ﹤0.01% 1154
2024
Q3
$1.33M Buy
281,200
+208,700
+288% +$1.21M ﹤0.01% 1276
2024
Q2
$542K Buy
+72,500
New +$889K ﹤0.01% 1845
2022
Q4
Sell
-54,400
Closed -$35K 2523
2022
Q3
$35K Sell
54,400
-130,900
-71% -$158K ﹤0.01% 2399
2022
Q2
$196K Buy
185,300
+1,200
+0.7% +$1.7K ﹤0.01% 2281
2022
Q1
$374K Buy
184,100
+106,000
+136% +$277K ﹤0.01% 2124
2021
Q4
$296K Buy
78,100
+38,000
+95% +$405K ﹤0.01% 2147
2021
Q3
$488K Buy
40,100
+27,800
+226% +$256K ﹤0.01% 1938
2021
Q2
$106K Sell
12,300
-3,600
-23% -$35.4K ﹤0.01% 2342
2021
Q1
$176K Buy
15,900
+1,100
+7% +$13.4K ﹤0.01% 2376
2020
Q4
$185K Sell
14,800
-1,800
-11% -$23.3K ﹤0.01% 2192
2020
Q3
$180K Sell
16,600
-400
-2% -$4.6K ﹤0.01% 2179
2020
Q2
$189K Buy
+17,000
New +$130K ﹤0.01% 2258

Other funds holding CABA

Two Sigma Advisers's CABA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 737,900 shares — an estimated $1.62M sold.

Two Sigma Advisers first reported a position in CABA in Q2 2020 and held it in 17 quarters. The position peaked at $1.89M in Q4 2024. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 737,900 Cabaletta Bio shares in Q1 2026, an estimated $1.62M.
  • Two Sigma Advisers first reported a position in Cabaletta Bio in Q2 2020 and held it in 17 quarters.
  • Two Sigma Advisers's Cabaletta Bio position peaked at $1.89M in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.